Silver | Product Launch, 2021

Kaleo, FCB Health Canada and Allerject, Fits Your Life

MM+M Staff

October 7, 2021

10:30 pm

Allerject, out to dethrone market leader EpiPen, knew it had a better auto-injector. It’s easier to carry and use, which helped it aim at the EpiPen’s weakness — it’s so bulky and cumbersome people leave it at home, defeating the purpose. So this launch didn’t just introduce a new auto-injector, it also launched a new behavior: actually carrying their injector. The effort exceeded sales forecasts by 23% in the first eight weeks.

Click to view MM+M 2021 Award Winners

From Our Partners

Thought leadership: The key to connecting with healthcare decision-makers

Partner Content

Thought leadership: The key to connecting with healthcare decision-makers

Organizations can partner with Advisory Board Sponsorship to create content and events that elevate their thought leadership.

Empowered engagement: How audience-centric strategies drive healthcare marketing success

Partner Content

Empowered engagement: How audience-centric strategies drive healthcare marketing success

During this conversation, hear from Swoop and Bayer about how brands can think differently about their targeting strategies to optimize engagement, improve patient outcomes, and drive Rx lift.

Will pharma finally reach out to minorities before the government forces their hand?

Partner Content

Will pharma finally reach out to minorities before the government forces their hand?

Why must the pharma industry consistently be positioned as an opponent? The government should seek “win-win” situations rather than “victories over …” situations. We still have a long way to go.

3 reasons the point of care is key for improving medication adherence

Partner Content

3 reasons the point of care is key for improving medication adherence

To overcome adherence obstacles, support needs to begin the moment a prescription is written and continue throughout the patient journey.